Profil
Dr. Peter G.
Milner, MD, is a Chief Executive Officer & Director at Renexxion LLC, an Executive Chairman at Armetheon, Inc., a Chairman at AshHill Investments LLC, a Chairman & Chief Executive Officer at Renexxion Ireland Ltd. and a Chief Executive Officer at Xyra LLC.
He is on the Board of Directors at Renexxion LLC, Optivia Biotechnology, Inc., Ischemix, Inc., Lifeline Technologies, Inc. and SinuSys Corp.
Dr. Milner was previously employed as a Principal by ML Laboratories Plc, a Director, President-Research & Development by ARYx Therapeutics, Inc., a Co-Founder by CV Therapeutics, Inc., a Scientific Advisor by ABV LLC, a Chief Executive Officer & Director by Heart Metabolics Ltd., and an Assistant Professor by Washington University in St. Louis.
He also served on the board at California Healthcare Institute, Retrotope, Inc. and Stem Cell Therapeutics Corp.
He received his doctorate degree from The University of Liverpool.
Postes actifs de Peter G. Milner
| Sociétés | Poste | Début |
|---|---|---|
Lifeline Technologies, Inc.
Lifeline Technologies, Inc. BiotechnologyHealth Technology Operates as a health sciences development company which focuses on novel strategies | Directeur/Membre du Conseil | - |
SinuSys Corp.
SinuSys Corp. Medical SpecialtiesHealth Technology Develops medical device therapies to improve the sinus health of patients with chronic sinusitis | Directeur/Membre du Conseil | - |
AshHill Investments LLC
AshHill Investments LLC Investment ManagersFinance AshHill Investments invests in companies located in the United States. The firm focuses on the biomedical sector. It participates in seed and early stage capital transactions. | Directeur Général | - |
Armetheon, Inc.
Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cardiovascular focused late-clinical stage specialty pharmaceutical company | Fondateur | 01/01/2011 |
Optivia Biotechnology, Inc.
Optivia Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Provides transporter assay services | Fondateur | 01/01/2007 |
Renexxion LLC
Renexxion LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Fondateur | 01/01/2014 |
Ischemix, Inc.
Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs | Directeur/Membre du Conseil | - |
Anciens postes connus de Peter G. Milner
| Sociétés | Poste | Fin |
|---|---|---|
Heart Metabolics Ltd.
Heart Metabolics Ltd. BiotechnologyHealth Technology Develops medical therapy for the treatment of heart failure | Directeur Général | 02/01/2015 |
| TRILLIUM THERAPEUTICS | Directeur/Membre du Conseil | 18/08/2011 |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░ ░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Peter G. Milner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Washington University in St. Louis
Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Trillium Therapeutics, Inc.
Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Optivia Biotechnology, Inc.
Optivia Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Provides transporter assay services | Health Technology |
ML Laboratories Plc
ML Laboratories Plc Miscellaneous Commercial ServicesCommercial Services Researches and develops a small number of ethical pharmaceutical and medical products | Commercial Services |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARYx Therapeutics, Inc.
ARYx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
ABV LLC
ABV LLC Investment ManagersFinance Ascent Biomedical invests in companies located in the United States. The fund targets companies operating in the fields of medical devices, biopharmaceuticals, healthcare services and information technology. It provides financing for seed and early stage capital requirements. | Finance |
California Healthcare Institute
California Healthcare Institute BiotechnologyHealth Technology Provides biomedical community services | Health Technology |
Lifeline Technologies, Inc.
Lifeline Technologies, Inc. BiotechnologyHealth Technology Operates as a health sciences development company which focuses on novel strategies | Health Technology |
Ischemix, Inc.
Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs | Health Technology |
Retrotope, Inc.
Retrotope, Inc. BiotechnologyHealth Technology Develops pipeline of proprietary therapeutics | Health Technology |
SinuSys Corp.
SinuSys Corp. Medical SpecialtiesHealth Technology Develops medical device therapies to improve the sinus health of patients with chronic sinusitis | Health Technology |
AshHill Investments LLC
AshHill Investments LLC Investment ManagersFinance AshHill Investments invests in companies located in the United States. The firm focuses on the biomedical sector. It participates in seed and early stage capital transactions. | Finance |
Armetheon, Inc.
Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cardiovascular focused late-clinical stage specialty pharmaceutical company | Health Technology |
Heart Metabolics Ltd.
Heart Metabolics Ltd. BiotechnologyHealth Technology Develops medical therapy for the treatment of heart failure | Health Technology |
Renexxion LLC
Renexxion LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
















